CDKN2A and melanoma: As seen in Table 1, the re-analysis enabled us to solve one case with an uncertain clinical diagnosis: a whole CDKN2A deletion causing melanoma and neural system tumor syndrome (OMIM: 155755) was identified in the patient with clinical suspicion of NF1 (Sample R2) (Supplementary Figure S5).